AAAAAA
Results: 1-25/45
Authors:
ENDRESZ V
KARI L
BERENCSI K
KARI C
GYULAI Z
JENEY C
PINCUS S
RODECK U
MERIC C
PLOTKIN SA
GONCZOL E
Citation: V. Endresz et al., INDUCTION OF HUMAN CYTOMEGALOVIRUS (HCMV)-GLYCOPROTEIN B (GB)-SPECIFIC NEUTRALIZING ANTIBODY AND PHOSPHOPROTEIN 65 (PP65)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE RESPONSES BY NAKED DNA IMMUNIZATION, Vaccine, 17(1), 1999, pp. 50-58
Authors:
ADLER SP
HEMPFLING SH
STARR SE
PLOTKIN SA
RIDDELL S
Citation: Sp. Adler et al., SAFETY AND IMMUNOGENICITY OF THE TOWNE STRAIN CYTOMEGALOVIRUS VACCINE, The Pediatric infectious disease journal, 17(3), 1998, pp. 200-206
Authors:
SADDIER P
FLORET D
GUESS HA
DURR F
PEYRIEUX JC
WEBER DJ
PLOTKIN SA
Citation: P. Saddier et al., COST OF VARICELLA IN FRANCE - A STUDY IN DAY-CARE-CENTERS, The Journal of infectious diseases, 178, 1998, pp. 58-63
Authors:
STRADY A
LANG J
LIENARD M
BLONDEAU C
JAUSSAUD R
PLOTKIN SA
Citation: A. Strady et al., ANTIBODY PERSISTENCE FOLLOWING PREEXPOSURE REGIMENS OF CELL-CULTURE RABIES VACCINES - 10-YEAR FOLLOW-UP AND PROPOSAL FOR A NEW BOOSTER POLICY, The Journal of infectious diseases, 177(5), 1998, pp. 1290-1295
Authors:
PLOTKIN SA
Citation: Sa. Plotkin, DEVELOPED-COUNTRIES SHOULD USE INACTIVATED POLIO VACCINE FOR THE PREVENTION OF POLIOMYELITIS, Reviews in medical virology, 7(2), 1997, pp. 75-81
Authors:
PLOTKIN SA
CADOZ M
Citation: Sa. Plotkin et M. Cadoz, ACELLULAR VACCINE EFFICACY TRIALS, The Pediatric infectious disease journal, 16(9), 1997, pp. 913-914
Authors:
PLOTKIN SA
CADOZ M
Citation: Sa. Plotkin et M. Cadoz, THE ACELLULAR PERTUSSIS-VACCINE TRIALS - AN INTERPRETATION, The Pediatric infectious disease journal, 16(5), 1997, pp. 508-517
Authors:
KLEIN PN
PLOTKIN SA
RAO S
TARDOS E
Citation: Pn. Klein et al., APPROXIMATION ALGORITHMS FOR STEINER AND DIRECTED MULTICUTS, Journal of algorithms, 22(2), 1997, pp. 241-269
Authors:
LANG J
HOA DQ
GIOI NV
THO LT
VIEN NC
KESMEDJIAN V
PLOTKIN SA
Citation: J. Lang et al., RANDOMIZED FEASIBILITY TRIAL OF PREEXPOSURE RABIES VACCINATION WITH DTP-IPV IN INFANTS, Lancet, 349(9066), 1997, pp. 1663-1665
Authors:
PLOTKIN SA
Citation: Sa. Plotkin, POLIO VACCINE PRODUCTION, Science, 278(5335), 1997, pp. 19-19
Authors:
PLOTKIN SA
LOUPI E
LANG J
Citation: Sa. Plotkin et al., BALI LOW - COMMENTARY, Pediatrics, 100(4), 1997, pp. 718-719
Authors:
IONNEDELCU N
STREBEL PM
TOMA F
BIBERIMOROEANU S
COMBIESCU M
PERSU A
AUBERTCOMBIESCU A
PLOTKIN SA
SUTTER RW
Citation: N. Ionnedelcu et al., SEQUENTIAL AND COMBINED USE OF INACTIVATED AND ORAL POLIOVIRUS VACCINES - DOLJ DISTRICT, ROMANIA, 1992-1994, The Journal of infectious diseases, 175, 1997, pp. 241-246
Authors:
PLOTKIN SA
Citation: Sa. Plotkin, 100 YEARS OF VACCINATION - THE LEGACY OF PASTEUR,LOUIS, The Pediatric infectious disease journal, 15(5), 1996, pp. 391-394
Authors:
PLOTKIN SA
FLETCHER MA
Citation: Sa. Plotkin et Ma. Fletcher, COMBINATION VACCINES AND IMMUNIZATION VISITS, The Pediatric infectious disease journal, 15(2), 1996, pp. 103-105
Authors:
BERENCSI K
GONCZOL E
ENDRESZ V
KOUGH J
TAKEDA S
GYULAY Z
PLOTKIN SA
RANDO RF
Citation: K. Berencsi et al., THE N-TERMINAL 303 AMINO-ACIDS OF THE HUMAN CYTOMEGALOVIRUS ENVELOPE GLYCOPROTEIN B (UL55) AND THE EXON-4 REGION OF THE MAJOR IMMEDIATE-EARLY PROTEIN-1 (UL123) INDUCE A CYTOTOXIC T-CELL RESPONSE, Vaccine, 14(5), 1996, pp. 369-374
Authors:
PLOTKIN SA
Citation: Sa. Plotkin, QUESTIONS ABOUT VARICELLA VACCINE - REPLY, Pediatrics, 98(6), 1996, pp. 1226-1226
Authors:
PLOTKIN SA
Citation: Sa. Plotkin, VARICELLA VACCINE, Pediatrics, 97(2), 1996, pp. 251-253
Authors:
ADLER SP
WANG JB
BURKE RL
DULIEGE AM
STARR SE
PLOTKIN SA
Citation: Sp. Adler et al., MUCOSAL ANTIBODIES TO CYTOMEGALOVIRUS (CMV) GLYCOPROTEIN-B (GB) OCCURFOLLOWING BOTH NATURAL INFECTION AND IMMUNIZATION WITH CMV VACCINES, Pediatric research, 39(4), 1996, pp. 973-973
Authors:
LANG J
HOA DQ
GIOI NV
PLOTKIN SA
Citation: J. Lang et al., FIRST RESULTS OF THE FEASIBILITY OF PREEXPOSURE RABIES VACCINATION ASSOCIATED WITH DTP-IPV DURING EPI SESSIONS IN INFANTS LIVING IN AN ENDEMIC COUNTRY, Pediatric research, 39(4), 1996, pp. 1046-1046
Authors:
WANG JB
ADLER SP
HEMPFLING S
BURKE RL
DULIEGE AM
STARR SE
PLOTKIN SA
Citation: Jb. Wang et al., MUCOSAL ANTIBODIES TO HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN-B OCCUR FOLLOWING BOTH NATURAL INFECTION AND IMMUNIZATION WITH HUMAN CYTOMEGALOVIRUS VACCINES, The Journal of infectious diseases, 174(2), 1996, pp. 387-392
Authors:
CLARK HF
OFFIT PA
ELLIS RW
EIDEN JJ
KRAH D
SHAW AR
PICHICHERO M
TREANOR JJ
BORIAN FE
BELL LM
PLOTKIN SA
Citation: Hf. Clark et al., THE DEVELOPMENT OF MULTIVALENT BOVINE ROTAVIRUS (STRAIN WC3) REASSORTANT VACCINE FOR INFANTS, The Journal of infectious diseases, 174, 1996, pp. 73-80
Authors:
PLOTKIN SA
Citation: Sa. Plotkin, INACTIVATED POLIO VACCINE FOR THE UNITED-STATES - A MISSED VACCINATION OPPORTUNITY, The Pediatric infectious disease journal, 14(10), 1995, pp. 835-839
Authors:
PLOTKIN SA
SHMOYS DB
TARDOS E
Citation: Sa. Plotkin et al., FAST APPROXIMATION ALGORITHMS FOR FRACTIONAL PACKING AND COVERING PROBLEMS, Mathematics of operations research, 20(2), 1995, pp. 257-301
Authors:
GONCZOL E
BERENCSI K
PINCUS S
ENDRESZ V
MERIC C
PAOLETTI E
PLOTKIN SA
Citation: E. Gonczol et al., PRECLINICAL EVALUATION OF AN ALVAC (CANARYPOX)-HUMAN CYTOMEGALOVIGRUSGLYCOPROTEIN-B VACCINE CANDIDATE, Vaccine, 13(12), 1995, pp. 1080-1085
Authors:
PLOTKIN SA
Citation: Sa. Plotkin, THE DUESBERG-PHENOMENON - DUESBERG AND OTHER VOICES, Science, 267(5196), 1995, pp. 315-316